المؤلفون: Maya Arvidsson Rådestig, Ingmar Skoog, Tobias Skillbäck, Henrik Zetterberg, Jürgen Kern, Anna Zettergren, Ulf Andreasson, Hanna Wetterberg, Silke Kern, Kaj Blennow

المصدر: Alzheimer's Research & Therapy. 15

مصطلحات موضوعية: Neurology, Cognitive Neuroscience, Neurology (clinical)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8de2feabb8406b6934bdbffceaa44ef9Test
https://doi.org/10.1186/s13195-023-01193-xTest

المؤلفون: Lori B. Chibnik, Osorio Meirelles, Joshua C. Bis, Christophe Tzourio, Bruce M. Psaty, Vilmundur Gudnason, Albert Hofman, Reem Waziry, Claudine Berr, Eric Boerwinkle, Catherine Helmer, Blossom C. M. Stephan, Carol Brayne, Frank J. Wolters, Alison Ower, Silke Kern, Lewis H. Kuller, Jean-François Dartigues, Ingmar Skoog, Mei Mei Wong, Leslie Grasset, M. Arfan Ikram, Anna Zettergren, M. Kamran Ikram, Fiona E. Matthews, Daniel Bos, Kristoffer Bäckman, Oscar L. Lopez, Thomas H. Mosley, Kendra Davis-Plourde, Lenore J. Launer, Stéphanie Debette, Sirwan K.L. Darweesh, Claudia L. Satizabal, Christoforos Hadjichrysanthou, Carole Dufouil, Myriam Fornage, Alexa S. Beiser, Sudha Seshadri

المساهمون: Epidemiology, Neurology, Radiology & Nuclear Medicine, Department of Epidemiology [Boston, MA, USA], Harvard School of Public Health, Brigham & Women’s Hospital [Boston] (BWH), Harvard Medical School [Boston] (HMS), Erasmus University Medical Center [Rotterdam] (Erasmus MC), University of Gothenburg (GU), School of Public Health [Boston], Boston University [Boston] (BU), Neuropsychiatrie : recherche épidémiologique et clinique (PSNREC), Université Montpellier 1 (UM1)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Department of Medicine, University of Washington [Seattle], The University of Texas School of Public Health [Houston, TX, USA], The University of Texas Health Science Center at Houston (UTHealth), Department of Public Health and Primary Care, University of Cambridge [UK] (CAM), Epidémiologie et Biostatistique [Bordeaux], Université Bordeaux Segalen - Bordeaux 2-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Neuroépidémiologie, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Icelandic Heart Association, Heart Preventive Clinic and Research Institute, Imperial College London, University of Pittsburgh (PITT), Pennsylvania Commonwealth System of Higher Education (PCSHE), National Institute on Aging [Bethesda, USA] (NIA), National Institutes of Health [Bethesda] (NIH), Nextel S.A. [Bilbao], University of Mississippi Medical Center (UMMC), Boston University School of Medicine (BUSM), Institute of Neuroscience and Physiology [Göteborg], Newcastle University [Newcastle], Institut de Santé Publique, d'Epidémiologie et de Développement (ISPED), Université Bordeaux Segalen - Bordeaux 2, The Alzheimer Cohorts Consortium is supported by an unrestricted grant from the Janssen Prevention Center to the Harvard T.H. Chan School of Public Health. Age, Gene/Environment Susceptibility (AGES) This study is supported by National Institute of Aging contracts (N01-AG-12100 and HHSN271201200022C) with contributions from the National Eye Institute, National Institute on Deafness and Other Communication Disorders, and the National Heart, Lung and Blood Institute, the National Institute of Aging Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament), Atherosclerosis Risk in Communities (ARIC) This study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). Neurocognitive data is collected by (U01 HL096812, HL096814, HL096899, HL096902, HL096917) with funding also provided by the National Institute of Neurologic Disorders and Stroke, Cardiovascular Health Study (CHS) This research was supported by contracts (HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086), and grants U01HL080295, U01HL130114 and HL105756 from the National Heart, Lung, and Blood Institute (NHLBI), with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided by the National Institute on Aging (R01AG023629) and, in part, by grants (AG20098, AG15928, and AG05133). The funding sources did not have any role in the study design, collection, analysis, or interpretation of data, preparation of the manuscript, or decision to submit it for publication, Cognitive Function and Ageing Studies (CFAS) Medical Research Council (MRC) CFAS I was funded by the MRC (Research Grant: G9901400) and the National Health Service (NHS). CFAS II has been supported by the UK Medical Research Council (Research Grant:G06010220) and received additional support from the National Institute for Health Research (NIHR), comprehensive clinical research networks in West Anglia, Nottingham City and Nottinghamshire County NHS Primary Care trusts and the dementias and neurodegenerative disease research Network (DeNDRoN) in Newcastle, Framingham Heart Study (FHS) This work was supported by the National Heart, Lung, and Blood Institute’s Framingham Heart Study (contracts N01-HC-25195 and HHSN268201500001I). This study was also supported by grants from the National Institute on Aging: (AG054076, U01-AG049505, and AG008122 (S. Seshadri)). S. Seshadri and A. Beiser were also supported by additional grants from the National Institute on Aging (R01AG049607, AG033193, AG033040) and the National Institute of Neurological Disorders and Stroke (R01-NS017950), The Gothenburg study This study was supported by grants from The Swedish Research Council 2012-5041, 2015-02830, 2013-8717, Swedish Research Council for Health, Working Life and Wellfare (no 2001-2646, 2003-0234, 2004-0150, 2006-0020, 2008-1229, 2012-1138, 2004-0145, 2006-0596, 2008-1111, 2010-0870, 2013-1202, 2001-2849, 2005-0762,2008-1210, 2013-2300, 013-2496, Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse, Hja¨rnfonden, Sahlgrenska University Hospital (ALF), The Alzheimer’s Association Zenith Award (ZEN-01-3151), The Alzheimer’s Association Stephanie B. Overstreet Scholars (IIRG-00-2159), Alzheimer’s Association (IIRG-03-6168), The Alzheimer’s Association (IIRG-09-131338), Eivind och ElsaK:son Sylvans stiftelse, Stiftelsen So¨derstro¨m-Ko¨nigska Sjukhemmet, Stiftelsen fo¨ r Gamla Tja¨narinnor, Handlanden Hjalmar Svenssons Forskningsfond, Stiftelsen Professor Bror Gadelius’ Minnesfond, Swedish Alzheimer foundation, PAQUID The PAQUID cohort was supported by IPSEN France, NOVARTIS Pharma France, and the CNSA (Caisse Nationale de Solidarité et d’Autonomie). This study is supported by the Erasmus Medical Centre and Erasmus University Rotterdam, The Netherlands Organization for Scientific Research (NWO), The Netherlands Organization for Health Research and Development (ZonMW), the Research Institute for Diseases in the Elderly (RIDE), The Netherlands Genomics Initiative, the Ministry of Education, Culture and Science, the Ministry of Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. Further support was obtained from the Netherlands Consortium for Healthy Ageing and the Dutch Heart Foundation (2012T008). This research was further supported by funding from the European Union Seventh Framework Program (FP7/2007e2013) under grant agreement no. 601055, VPHDare@ IT (FP7-ICT-2011-9e601055), and funding from the European Union’s Horizon 2020 research and innovation program under grant agreement no. 667375 (Co-STREAM) and under grant agreement no. 678543 (European Research Council (ERC) funded project: ORACLE). None of the funding organizations or sponsors were involved in study design, in collection, analysis, and interpretation of data, in writing of the report, or in the decision to submit the article for publication, The 3-Cites Study This study is conducted under a partnership agreement among the Institut National de la Santé et de la Recherche Médicale (INSERM), the Victor Segalen–Bordeaux II University, and Sanofi-Aventis. The Fondation pour la Recherche Médicale funded the preparation and initiation of the study. The 3C Study is also supported by the Caisse Nationale Maladie des Travailleurs Salariés, Direction Générale de la Santé, Mutuelle Générale de l’Education Nationale (MGEN), Institut de la Longévité, Conseils Régionaux of Aquitaine and Bourgogne, Fondation de France, and Ministry of Research–INSERM Programme ‘‘Cohortes et collections de donne´es biologiques’’, Infrastructure for the CHARGE Consortium is supported in part by National Heart, Lung and Blood Institute (HL105756) and for the neurology working group by National Institutes of Aging (AG033193 and AG049505)., Berr, Claudine, Brayne, Carol [0000-0001-5307-663X], Matthews, Fiona [0000-0002-1728-2388], Apollo - University of Cambridge Repository

المصدر: European Journal of Epidemiology, 32(10), 931-938. Springer Netherlands
European Journal of Epidemiology
European Journal of Epidemiology, 2017, 32 (10), pp.931-938. ⟨10.1007/s10654-017-0320-5⟩
European Journal of Epidemiology, Springer Verlag, 2017, 32 (10), pp.931-938. ⟨10.1007/s10654-017-0320-5⟩

مصطلحات موضوعية: Male, Gerontology, medicine.medical_specialty, Epidemiology, [SDV]Life Sciences [q-bio], Population, Cohort Studies, New Consortium, 03 medical and health sciences, symbols.namesake, 0302 clinical medicine, medicine, Humans, Dementia, Prospective Studies, 030212 general & internal medicine, Poisson regression, education, Aged, Proportional Hazards Models, Aged, 80 and over, education.field_of_study, Proportional hazards model, business.industry, Incidence, Incidence (epidemiology), medicine.disease, 3. Good health, [SDV] Life Sciences [q-bio], 1117 Public Health And Health Services, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Population Surveillance, Cohort, symbols, Female, Gene-Environment Interaction, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Alzheimer disease, Cohort analysis, business, Consortium, 030217 neurology & neurosurgery, Cohort study

وصف الملف: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11399c348a7ccb8107326fbd2600d2d0Test
https://doi.org/10.1007/s10654-017-0320-5Test

المؤلفون: Daniel R. Whiten, David Klenerman, Dimitrios I Sideris, Suman De, Craig D. Hughes, Francesco A. Aprile, Silke Kern, Tuomas P. J. Knowles, Ingmar Skoog, Christopher G. Taylor, Serge Muyldermans, Henrik Zetterberg, Clare E. Bryant, Francesco Simone Ruggeri, Michele Vendruscolo, Margarida Rodrigues, Kaj Blennow

المساهمون: Klenerman, David [0000-0001-7116-6954], Apollo - University of Cambridge Repository

المصدر: Acta Neuropathologica Communications, 7(1), 120-120
Acta Neuropathologica Communications
Acta Neuropathologica Communications 7 (2019) 1
Acta Neuropathologica Communications, Vol 7, Iss 1, Pp 1-13 (2019)

مصطلحات موضوعية: 0301 basic medicine, Male, medicine.medical_specialty, Neurology, education, tau Proteins, Protein aggregation, lcsh:RC346-429, Pathology and Forensic Medicine, Super-resolution imaging, 03 medical and health sciences, Cellular and Molecular Neuroscience, Protein Aggregates, 0302 clinical medicine, Cerebrospinal fluid, Alzheimer Disease, Internal medicine, medicine, Animals, Humans, Cognitive Dysfunction, health care economics and organizations, lcsh:Neurology. Diseases of the nervous system, Aged, Amyloid beta-Peptides, Mechanism (biology), Chemistry, Atomic force microscopy, Research, Disease progression, Mild cognitive impairment, medicine.disease, 3. Good health, 030104 developmental biology, Endocrinology, Structure-function relation, Toxicity, Disease Progression, Disease mechanism, Female, Neurology (clinical), Alzheimer's disease, Camelids, New World, Alzheimer’s disease, 030217 neurology & neurosurgery, Biomarkers

وصف الملف: application/pdf; application/octet-stream; text/html; application/zip; text/xml; application/vnd.openxmlformats-officedocument.wordprocessingml.document

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be9abfd898c20ee03ee2eb0a0c069912Test

المؤلفون: Kaj Blennow, A Börjesson-Hansson, A Zettergren, Henrik Zetterberg, Silke Kern, Kina Höglund, Ingmar Skoog

المصدر: Translational Psychiatry

مصطلحات موضوعية: Male, Vascular Endothelial Growth Factor A, Amyloid pathology, Tau pathology, Apolipoprotein E4, tau Proteins, Bioinformatics, Cellular and Molecular Neuroscience, Alzheimer Disease, Neurofilament Proteins, medicine, Humans, Chitinase-3-Like Protein 1, Biological Psychiatry, Aged, Aged, 80 and over, Sweden, Orexins, Amyloid beta-Peptides, business.industry, Brain-Derived Neurotrophic Factor, Neurodegeneration, Correction, Myelin Basic Protein, Phosphoproteins, medicine.disease, Healthy Volunteers, Peptide Fragments, Psychiatry and Mental health, Cross-Sectional Studies, Neurocalcin, Biomarker (medicine), Female, Neurogranin, Original Article, business, Fatty Acid Binding Protein 3, Biomarkers

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87315816d4cc1839412fd2c9325360caTest
https://doi.org/10.1038/s41398-018-0301-9Test

المؤلفون: A Börjesson-Hansson, Silke Kern, Kina Höglund, Ingmar Skoog, Kaj Blennow, A Zettergren, Henrik Zetterberg

المصدر: Translational Psychiatry. 7:e995-e995

مصطلحات موضوعية: 0301 basic medicine, Pathology, medicine.medical_specialty, business.industry, Neurodegeneration, Disease, medicine.disease, 03 medical and health sciences, Cellular and Molecular Neuroscience, Psychiatry and Mental health, 030104 developmental biology, 0302 clinical medicine, Cerebrospinal fluid, medicine, Dementia, Biomarker (medicine), Neurogranin, Alzheimer's disease, business, Pathological, 030217 neurology & neurosurgery, Biological Psychiatry

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f0beaaf2edb37a1b842b3e0bdbdf6ecdTest
https://doi.org/10.1038/tp.2016.252Test